Overcoming obstacles to immunization in patients with chronic liver disease

American Journal of Medicine

Volumn 118, Issue 10 SUPPL., 2005, Pages 40-45

  Bockhold, Kathleen ^a,c   Riely, Caroline A ^b,c   Jeffreys, Chantil ^d  

^a Division of Gastroenterology   (United States)

^b Departments of Medicine and Pediatrics   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d Pathology Group of the Midsouth   (United States)

Author keywords

Chronic liver disease; Hepatitis A; Hepatitis B; Immunization; Screening; Vaccination

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

CAUSE OF DEATH; CHRONIC LIVER DISEASE; DRUG COST; DRUG SAFETY; HEALTH CARE AVAILABILITY; HEALTH INSURANCE; HEALTH PROGRAM; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION RISK; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMINDER SYSTEM; REVIEW; RISK ASSESSMENT; SCREENING; VACCINATION;

EID: 27644547657     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.015     Document Type: Article

References (29)

1. Department of Health and Human Services Healthy People 2010 Understanding and Improving Health 2nd ed. 2000 US Government Printing Office Washington, DC November
2. Centers for Disease Control and Prevention. Disease burden from viral hepatitis A, B, and C in the United States. Available at: http://www.cdc.gov/ ncidod/diseases/hepatitis/resource/pdfs/disease_burden2004.pdf. Accessed May 17, 2005.
3. E.B. Keeffe Acute hepatitis A and B in patients with chronic liver disease prevention through vaccination Am J Med. 118 suppl 10A 2005 21S 27S
4. G. Reiss, E.B. Keeffe Hepatitis vaccination in patients with chronic liver disease Aliment Pharmacol Ther 19 2004 715 727
5. Children's Hospital of Philadelphia. [Vaccine Education Center Website]. A look at each vaccine: hepatitis A vaccine. Available at: http://www.chop.edu/ consumer/jsp. Accessed January 9, 2005.
6. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 48 RR-12 1999 1 38
7. Centers for Disease Control and Prevention Recommended adult immunization schedule - United States, October 2004-September 2005 MMWR Morb Mortal Wkly Rep 53 2004 Q1 Q4
8. Centers for Disease Control and Prevention. Vaccines to prevent hepatitis A and hepatitis B: September 2002. Available at: http://www.cdc.gov/idu/ hepatitis/vaccines.htm. Accessed May 22, 2005.
9. Centers for Disease Control and Prevention Hepatitis A M.D. Waldorf Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) 8th ed. 2005 Public Health Foundation 177 189
10. Immunization Action Coalition. Hepatitis A vaccination recommendations and policies. Available at: http://www.immunize.org/laws/hepa.htm. Accessed May 18, 2005.
11. Havrix (hepatitis A vaccine, inactivated) [package insert] 2005 GlaxoSmithKline Research Triangle Park, NC
12. Vaqta (hepatitis A vaccine, inactivated) [package insert] 2005 Merck & Co, Inc Whitehouse Station, NJ
13. Engerix-B (hepatitis B vaccine, recombinant) [package insert] 2004 GlaxoSmithKline Research Triangle Park, NC
14. Recombivax HB (hepatitis B vaccine, recombinant) [package insert] 2004 Merck & Co, Inc Whitehouse Station, NJ
15. Twinrix (hepatitis A inactivated and hepatitis B, recombinant) vaccine [package insert] 2003 GlaxoSmithKline Research Triangle Park, NC
16. A.S. Craig, W. Schaffner Prevention of hepatitis A with the hepatitis A vaccine N Engl J Med 350 2004 476 481
17. Centers for Disease Control and Prevention Hepatitis B M.D. Waldorf Epidemiology and Prevention of Vaccine-Preventable Diseases 8th ed. 2005 Public Health Foundation 191 212 (The Pink Book)
18. The Hepatitis Information Network. Hepatitis B vaccine is life-saving contrary to news reports this week [news report]. HepNews. January 25, 1999. Available at: http://www.hepnet.com/hepb/news012599.html. Accessed June 8, 2005.
19. Centers for Disease Control and Prevention. Medical management of chronic hepatitis B and chronic hepatitis C: September 2002. Available at: http://www.cdc.gov/idu/hepatitis/manage_chronich_hep_b-c.htm. Accessed May 23, 2005.
20. Lok ASF, McMahon BJ. AASLD practice guidelines: chronic hepatitis B. Available at: http://www.aasld.org/eweb/docs/chronichep_B.pdf. Accessed January 3, 2005.
21. D.B. Strader, T. Wright, D.L. Thomas, L.B. Seeff AASLD practice guideline diagnosis, management, and treatment of hepatitis C Hepatology 39 2004 1147 1168
22. National Institutes of Health NIH consensus statement on management of hepatitis C 2002 NIH Consens State Sci Statements 19 2002 1 46
23. Centers for Medicare and Medicaid Services. Available at: http://www.cms.hhs.gov. Accessed June 8, 2005.
24. M. Duncan, W.K. Hirota, A. Tsuchida Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease a prospective cost analysis Am J Gastroenterol 97 2002 1792 1795
25. M.R. Arguedas, G.R. Heudebert, M.B. Fallon, A.A. Stinnett The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States Am J Gastroenterol 97 2002 721 728
26. K.L. Nichol, R. MacDonald, M. Hauge Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults J Gen Intern Med 11 1996 673 677
27. N.V. Oster, C.A. McPhillips-Tangum, F. Averhoff, K. Howell Barriers to adolescent immunization a survey of family physicians and pediatricians J Am Board Fam Pract 18 2005 13 19
28. Centers for Disease Control and Prevention Adult immunization knowledge, attitudes, and practices - DeKalb and Fulton Counties, Georgia, 1988 MMWR Morb Mortal Wkly Rep 37 1988 657 661
29. B.C. Willis, S.M. Ndiaye, D.P. Hopkins, A. Shefer Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk MMWR Morb Mortal Wkly Rep 54 RR05 2005 1 11